Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hematology
Volume 2014, Article ID 841787, 3 pages
http://dx.doi.org/10.1155/2014/841787
Case Report

Familial Essential Thrombocythemia Associated with MPL W515L Mutation in Father and JAK2 V617F Mutation in Daughter

1Department of Medical Genetics, “Iuliu Hatieganu” University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania
2Department of Haematology, “Ion Chiricuta” Cancer Institute, Cluj-Napoca, Romania

Received 28 August 2014; Revised 8 October 2014; Accepted 13 October 2014; Published 10 November 2014

Academic Editor: Stephen Langabeer

Copyright © 2014 Adrian P. Trifa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. E. Langabeer, K. Haslam, and J. Linders, “Molecular heterogeneity of familial myeloproliferative neoplasms revealed by analysis of the commonly acquired JAK2, CALR and MPL mutations,” Familial Cancer, 2014. View at Publisher · View at Google Scholar
  2. A. V. Jones and N. C. Cross, “Inherited predisposition to myeloproliferative neoplasms,” Therapeutic Advances in Hematology, vol. 4, no. 4, pp. 237–253, 2013. View at Google Scholar
  3. O. Landgren, L. R. Goldin, S. Y. Kristinsson, E. A. Helgadottir, J. Samuelsson, and M. Björkholm, “Increased risks of polycythemia vera, essential thrombocythemia, and myelofibrosis among 24 577 first-degree relatives of 11 039 patients with myeloproliferative neoplasms in Sweden,” Blood, vol. 112, no. 6, pp. 2199–2204, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Pardanani, B. L. Fridley, T. L. Lasho, D. G. Gilliland, and A. Tefferi, “Host genetic variation contributes to phenotypic diversity in myeloproliferative disorders,” Blood, vol. 111, no. 5, pp. 2785–2789, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. A. V. Jones, P. J. Campbell, P. A. Beer et al., “The JAK2 46/1 haplotype predisposes to MPL-mutated myeloproliferative neoplasms,” Blood, vol. 115, no. 22, pp. 4517–4523, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Oddsson, S. Y. Kristinsson, H. Helgason et al., “The germline sequence variant rs2736100_C in TERT associates with myeloproliferative neoplasms,” Leukemia, vol. 28, no. 6, pp. 1371–1374, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Jäger, A. S. Harutyunyan, and E. Rumi, “Common germline variation at the TERT locus contributes to familial clustering of myeloproliferative neoplasms,” American Journal of Hematology, 2014. View at Publisher · View at Google Scholar
  8. A. V. Jones, S. Kreil, K. Zoi et al., “Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders,” Blood, vol. 106, no. 6, pp. 2162–2168, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. L. V. Furtado, H. C. Weigelin, K. S. J. Elenitoba-Johnson, and B. L. Betz, “Detection of MPL mutations by a novel allele-specific PCR-based strategy,” Journal of Molecular Diagnostics, vol. 15, no. 6, pp. 810–818, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. A. P. Trifa, A. Cucuianu, and R. A. Popp, “Development of a reliable PCR-RFLP assay for investigation of the JAK2 rs10974944 SNP, which might predispose to the acquisition of somatic mutation JAK2V617F,” Acta Haematologica, vol. 123, no. 2, pp. 84–87, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Rosen and H. J. Skaletsky, “Primer3 on the WWW for general users and for biologist programmers,” in Bioinformatics Methods and Protocols: Methods in Molecular Biology, S. Krawetz and S. Misener, Eds., pp. 365–386, Humana Press, Totowa, NJ, USA, 2000. View at Google Scholar
  12. D. Olcaydu, E. Rumi, A. Harutyunyan et al., “The role of the JAK2 GGCC haplotype and the TET2 gene in familial myeloproliferative neoplasms,” Haematologica, vol. 96, no. 3, pp. 367–374, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Malak, M. Labopin, C. Saint-Martin, C. Bellanne-Chantelot, and A. Najman, “Long term follow up of 93 families with myeloproliferative neoplasms: Life expectancy and implications of JAK2V617F in the occurrence of complications,” Blood Cells, Molecules, and Diseases, vol. 49, no. 3-4, pp. 170–176, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Maffioli, A. Genoni, D. Caramazza et al., “Looking for CALR mutations in familial myeloproliferative neoplasms,” Leukemia, vol. 28, no. 6, pp. 1357–1360, 2014. View at Publisher · View at Google Scholar · View at Scopus